Preoperative serum vascular endothelial growth factor levels: Significance in ovarian cancer

Clinical Cancer Research

Volumn 8, Issue 10, 2002, Pages 3193-3197

  Cooper, Brian C ^a   Ritchie, Justine M ^a   Broghammer, Carrie L W ^a   Coffin, Jeremy ^a   Sorosky, Joel I ^a   Buller, Richard E ^a   Hendrix, Mary J C ^a   Sood, Anil K ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; ASCITES; BENIGN TUMOR; CANCER GRADING; CANCER INVASION; CANCER STAGING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OVARY CANCER; OVARY TUMOR; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; CA-125 ANTIGEN; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MIDDLE AGED; OVARIAN NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036793818     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Folkman J. The role of angiogenesis in tumor growth. Semin. Cancer Biol., 3: 65-71, 1992.
2. Ferrara N. Vascular endothelial growth factor. Eur. J. Cancer 32A: 2413-2422, 1996.
3. Ferrara N., and Davis-Smyth, T. The biology of vascular endothelial growth factor. Endocrine Rev., 18: 4-25, 1997.
4. Hazelton D. A., and Hamilton, T. C. Vascular endothelial growth factor in ovarian cancer. Curr. Oncol. Rep., 1: 59-63, 1999.
5. Paley P. J., Staskus, K. A., Gebhard, K., Mohanraj, D., Twiggs, L. B., Carson, L. F., and Ramakrishnan, S. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer (Phila.), 80: 98-106, 1997.
6. Yamamoto S., Konishi, I., Mandai, M., Kuroda, H., Komatsu, T., Nanbu, K., Sakahara, H., and Mori, T. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br. J. Cancer, 76: 1221-1227, 1997.
7. Kraft A., Weindel, K., Ochs, A., Marth, C., Zmija, J., Schumacher, P., Unger, C., Marmé, D., and Gasti, G. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (Phila.), 85: 178-187, 1999.
8. Tempfer C., Obermair, A., Hefler, L., Haeusler, G., Gitsch, G., and Kainz, C. Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet. Gynecol., 92: 360-363, 1998.
9. Chen C., Cheng, W., Lee, C., Chen, T., Kung, C. S., Hsieh, F., and Hsieh, C. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Gynecol. Oncol., 74: 235-240, 1999.
10. Gadducci A., Ferdeghini, M., Fanucchi, A., Annicchiarico, C., Ciampi, B., Prontera, B., and Genazzani, A. R. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship wit prognostic variable and clinical outcome. Anticancer Res., 19: 1401-1406, 1999.
11. Obermair A., Tempfer, C., Hefler, L., Preyer, O., Kaider, A., Zellinger, R., Leodolter, S., and Kainz, C. Concentration of vascular endothelial growth factor (VEGF) in the serum of patients with suspected ovarian cancer. Br. J. Cancer, 77: 1870-1874, 1998.
12. Oehler M. K., and Caffier, H. Diagnostic value of serum VEGF in women with ovarian tumors. Anticancer Res., 19: 2519-2522, 1999.
13. Lee, J. K., Hong, Y. J., Han, C. J., Hwang, D. Y., and Hong, S. I. Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen? Int. J. Oncol., 17: 149-152, 2000.
14. Kumar H., Heer, K. Lee, P. W. R., Duthie, G. S., MacDonald, A. W., Greenman, J., Kerin, M. J., and Monson, J. R. T. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin. Cancer Res., 4: 1279-1285, 1998.
15. Takano S., Yoshio, Y., Kondo, S., Suzuki, H., Maruno, T., Shirai, S., and Nose, T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res., 56: 2185-2190, 1996.
16. Takashi A., Sasaki, H., Kim, S. J. Tobisu, K-I. Kakizoe, T., Tsukamoto, T., Kumamoto, Y., Sugimura, T., and Terada, M. Markedly increased amounts of mRNAs for vascular endothelial growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res., 54: 4233-4237, 1994.
17. Toi, M., Kondo, S., Suzuki, H., Yamamoto, Y., Inada, K., Imazawa, T., Taniguchi, T., and Tominaga, T. Quantitative analysis of vascular endothelial growth factor in primary breast carcinoma. Cancer (Phila.), 77: 1101-1106, 1996.
18. Shweiki D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
19. Buller R. E., Vasilev, S., and DiSaia, P. J. CA 125 kinetics: a cost-effective clinical tool to evaluate clinical trial outcomes in the 1990s. Am. J. Obstet. Gynecol., 174: 1241-1254, 1996.
20. Cooper B. C., Sood, A. K., Davis, C. S., Ritchie, J. M., Sorosky, J. I., Anderson B., and Buller, R. E. Preoperative CA-125 levels: an independent prognostic factor for epithelial ovarian cancer. Obstet. Gynecol., 100: 59-64, 2002.